Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation
- PMID: 20105585
- DOI: 10.1016/j.jpedsurg.2009.10.014
Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation
Abstract
Purpose: Intestinal failure (IF)-associated liver disease (IFALD) complicates the treatment of children with IF receiving parenteral nutrition (PN). We hypothesized that prevention or resolution of IFALD was possible in most children and that this would result in improved outcomes.
Methods: We reviewed prospectively gathered data on all children referred to the intestinal rehabilitation and transplantation center at our institution. Total bilirubin level (TB) was used as the marker for IFALD. Patients were grouped based on TB at referral and at subsequent inpatient stays and outpatient visits. Standard treatment consisted of cycling of PN, limiting lipid infusion, enteral stimulation, use of ursodeoxycholic acid, and surgical intervention when necessary. Outcomes such as mortality, dependence on PN, and need for transplantation were assessed. Statistical analyses were performed using Fisher's exact, Mann-Whitney U, and Wilcoxon signed rank tests.
Results: Ninety-three patients with intestinal failure and on PN were treated at our center from 2003 to 2009. Median age at referral was 5 months (0.5-264 months). Prematurity was a complicating factor in 63 patients and necrotizing enterocolitis was the most common diagnosis. Eighty-two children had short bowel syndrome, whereas the remaining 11 had extensive motility disorders. 97% of children required significant alteration of their PN administration. At referral, 76 of 93 children had TB 2.0 mg/dL or higher, and 17 had TB below 2.0 mg/dL. TB normalized in 57 of 76 children with elevated TB at referral, and TB remained elevated in 19. Normalization of TB was associated with a mortality of 5.2%, and transplantation was needed in 5.2%. Conversely, when TB remained elevated, mortality was 58% (P = .0002 vs TB normalized), and transplantation occurred in 58% owing to failure of surgical and medical rehabilitation.
Conclusions: Most children referred for treatment of IF have IFALD. A dedicated IF rehabilitation program can reverse IFALD in many children, and this is associated with improved outcome.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure.J Pediatr Gastroenterol Nutr. 2007 Aug;45(2):204-12. doi: 10.1097/MPG.0b013e31805905f9. J Pediatr Gastroenterol Nutr. 2007. PMID: 17667717
-
Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease.Eur J Pediatr Surg. 2009 Dec;19(6):348-53. doi: 10.1055/s-0029-1241865. Epub 2009 Oct 28. Eur J Pediatr Surg. 2009. PMID: 19866409
-
Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition.J Pediatr Surg. 2012 Feb;47(2):359-62. doi: 10.1016/j.jpedsurg.2011.11.032. J Pediatr Surg. 2012. PMID: 22325390
-
The prevention and treatment of intestinal failure-associated liver disease in neonates and children.Surg Clin North Am. 2011 Jun;91(3):543-63. doi: 10.1016/j.suc.2011.02.003. Epub 2011 Apr 15. Surg Clin North Am. 2011. PMID: 21621695 Review.
-
Short bowel syndrome and intestinal transplantation in children.Curr Opin Clin Nutr Metab Care. 2006 May;9(3):304-13. doi: 10.1097/01.mco.0000222116.68912.fc. Curr Opin Clin Nutr Metab Care. 2006. PMID: 16607133 Review.
Cited by
-
Enteral nutrient deprivation in patients leads to a loss of intestinal epithelial barrier function.Surgery. 2015 Apr;157(4):732-42. doi: 10.1016/j.surg.2014.12.004. Epub 2015 Feb 20. Surgery. 2015. PMID: 25704423 Free PMC article.
-
Variability of resting energy expenditure in infants and young children with intestinal failure-associated liver disease.J Pediatr Gastroenterol Nutr. 2014 May;58(5):637-41. doi: 10.1097/MPG.0000000000000288. J Pediatr Gastroenterol Nutr. 2014. PMID: 24361903 Free PMC article.
-
The extent of intestinal failure-associated liver disease in patients referred for intestinal rehabilitation is associated with increased mortality: an analysis of the Pediatric Intestinal Failure Consortium database.J Pediatr Surg. 2018 Jul;53(7):1399-1402. doi: 10.1016/j.jpedsurg.2017.08.049. Epub 2017 Sep 5. J Pediatr Surg. 2018. PMID: 28943136 Free PMC article.
-
Advanced Lipid Technologies® (ALT®): A Proven Formulation Platform to Enhance the Bioavailability of Lipophilic Compounds.J Drug Deliv. 2019 Jul 8;2019:1957360. doi: 10.1155/2019/1957360. eCollection 2019. J Drug Deliv. 2019. PMID: 31360551 Free PMC article. Review.
-
Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants.JPEN J Parenter Enteral Nutr. 2012 Jan;36(1 Suppl):81S-94S. doi: 10.1177/0148607111424411. JPEN J Parenter Enteral Nutr. 2012. PMID: 22237883 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous